All lobbying filings

Ferox Strategies

Ferox Strategies filed a Q4 report for Surgenex on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Surgenex · Medical biotechnology manufacturer

As filed: FEROX STRATEGIES for SURGENEX.

All filings by Ferox Strategies · Everything Surgenex has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Arizona

Official filing document

Lobbyists on this filing 1

MICHAEL TAGGART New on this filing

Previously held: Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

General issues related to skin substitutes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.